High frequency of deficient consumption and low blood levels of 25-hydroxyvitamin D in HIV-1-infected adults from Sao Paulo city, Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
9
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
NATURE PUBLISHING GROUP
Citação
SCIENTIFIC REPORTS, v.5, article ID 12990, 6p, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Micronutrient deficiency is common in patients with HIV/AIDS, usually caused by mal-absorption and/or drug interactions. 25-hydroxyvitamin D is of fundamental importance for the homeostasis of musculoskeletal health. The current study aimed to evaluate the nutritional status of HIV-infected subjects in order to make their nutritional diagnoses, including their vitamin D blood levels, and to estimate their consumption of vitamin D. The study included 98 HIV-1-infected subjects, followed at University of Sao Paulo Medical School -HC-FMUSP. We performed a nutritional evaluation, along with the determination of patients' serum 25-hydroxyvitamin D and calcium concentration, biochemical analyses, and an anthropometric assessment. In the medical interview a 24-hour food recall was used (R24) to estimate daily calorie intake, macronutrients, calcium, and vitamin D. A high level of vitamin D deficiency was observed in our patients: 83.4% of them had levels below 30 ng/ml; they also presented an increased risk of cardiovascular disease, along with a high consumption of dietary fat. Factors related to the virus itself and to the use of antiretroviral drugs may have contributed for the low vitamin D levels seen in our HIV-1-infected patients.
Palavras-chave
Referências
  1. [Anonymous], 2013, MS SECR VIG SD PROG, V201, P66
  2. [Anonymous], 2002, WHO, V3, P95
  3. Bandeira Francisco, 2006, Arq Bras Endocrinol Metabol, V50, P640, DOI 10.1590/S0004-27302006000400009
  4. Bueno AL, 2008, J PEDIAT, V84, P386, DOI [10.2223/JPED.1816, 10.1590/S0021-75572008000600003]
  5. Calvo MS, 2005, J NUTR, V135, P310
  6. Cozzolino M, 2003, AIDS, V17, P513, DOI 10.1097/01.aids.0000050817.06065.f8
  7. Deckers MML, 2013, CLIN CHIM ACTA, V426, P41, DOI 10.1016/j.cca.2013.08.024
  8. Deeks S. G., 2009, BMJ-BRIT MED J, V338, P186
  9. Gautam N, 2014, INDIAN J PEDIATR, V81, P1315, DOI 10.1007/s12098-014-1407-6
  10. Havers F, 2014, J INFECT DIS, V210, P244, DOI 10.1093/infdis/jiu259
  11. Holick MF, 2006, PROG BIOPHYS MOL BIO, V92, P49, DOI 10.1016/j.pbiomolbio.2006.02.014
  12. Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553
  13. Holick MF, 2006, MAYO CLIN PROC, V81, P353
  14. Kruzich LA, 2004, J AM DIET ASSOC, V104, P1554, DOI 10.1016/j.jada.2004.07.031
  15. Ponda MP, 2014, J CLIN ENDOCR METAB, V99, P2494, DOI 10.1210/jc.2014-1181
  16. Premaor Melissa Orlandin, 2006, Arq Bras Endocrinol Metabol, V50, P25, DOI 10.1590/S0004-27302006000100005
  17. Rodriguez-Martinez MA, 2002, PHARMACOL THERAPEUT, V93, P37, DOI 10.1016/S0163-7258(02)00164-X
  18. Soares FMG, 2013, AN BRAS DERMATOL, V88, P570, DOI 10.1590/abd1806-4841.2013895
  19. Tedaldi EM, 2006, JAIDS-J ACQ IMM DEF, V43, P35, DOI 10.1097/01.qai.0000234084.11291.d4
  20. Theodorou M, 2014, CLIN NUTR, V33, P274, DOI 10.1016/j.clnu.2013.04.018
  21. van der Sande MAB, 2004, JAIDS-J ACQ IMM DEF, V37, P1288, DOI 10.1097/01.qai.0000122708.59121.03
  22. Vieth R, 2006, PROG BIOPHYS MOL BIO, V92, P26, DOI 10.1016/j.pbiomolbio.2006.02.003
  23. Villamor E, 2006, NUTR REV, V64, P226, DOI 10.1301/nr.2006.may.226-233
  24. Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127
  25. Webb AR, 2006, PROG BIOPHYS MOL BIO, V92, P17, DOI 10.1016/j.pbiomolbio.2006.02.004